Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 4 1Phase 3 1Phase 1/2 1

Status

Not yet recruiting 2Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Neoplasm Metastasis 2Prostatic Neoplasms 1Melanoma 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Specimen Handling 273Magnetic Resonance Spectroscopy 224pembrolizumab 214Carboplatin 173Biopsy 166Cisplatin 159Nivolumab 149Cyclophosphamide 133Radiotherapy 117Paclitaxel 117Gemcitabine 112Bevacizumab 92durvalumab 86Dexamethasone 80Rituximab 76Oxaliplatin 73atezolizumab 68Capecitabine 67venetoclax 66Fluorouracil 66Doxorubicin 65Docetaxel 65Etoposide 63Radiosurgery 60Radiation 57Prednisone 57Cytarabine 56Ipilimumab 55Pemetrexed 54Taxes 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Denosumab × 90 days × Clear all
NCT07043608 2026-05-01

ZAMBONI

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT07537972 2026-04-17

Denosumab Strategy for Liver Cancer With Bone Metastases

Tongji Hospital

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03869762 2026-04-13

DICE

Cancer Trials Ireland

Phase 2 Terminated
7 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

NCT03620019 2026-03-27

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
25 enrolled 16 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡